Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00246974
Status:
COMPLETED
Last Update Posted:
2008-10-15
First Post:
2005-10-31
Brief Title:
Phase II Gemcitabine Cisplatin - Iressa Bladder CCT
Sponsor:
Organization:
AstraZeneca